Test Price
2,800 AED✅ Home Collection Available
NKX2‑2 Gene Sequencing for Maturity‑Onset Diabetes of the Young (MODY) – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين NKX2‑2 لمرض السكري الشبابي الناضج (MODY) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي: دقة تشخيصية 99.9% عبر تقنية التسلسل الجيني من الجيل التالي المتوافقة تماماً مع مواصفات الآيزو 9001:2015.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing with full‑coverage of the NKX2‑2 gene (coding, splice sites, promoter).
- Premium Logistics: Hospital‑Grade Home Collection by DHA‑licensed phlebotomists (8 AM–11 PM). Cold‑chain transport extends DNA stability for 96 hours.
- Clinical Guidance: Complimentary post‑test telehealth consultation with a diabetologist/genetic counsellor for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – most major UAE insurers approved.
Overview: Precision MODY Genetic Testing in the UAE
This advanced NKX2‑2 Genetic Test identifies pathogenic variants in the NKX2‑2 gene, enabling precise subtyping of maturity‑onset diabetes of the young (MODY) and guiding personalised therapy. يحدد هذا التحليل الجيني التغيرات المرضية في جين NKX2‑2 بدقة فائقة، مما يمكّن من تشخيص دقيق لمرض السكري الشبابي الناضج. Whether you are newly diagnosed with non‑obese diabetes, have a strong family history, or seek clarity for reproductive planning, our DHA‑compliant protocol delivers definitive answers.
| Feature | Our Test – NKX2‑2 NGS Panel | Closest Alternative (Targeted Sanger Sequencing) |
|---|---|---|
| Precision | Full‑gene coverage (coding ±10 bp, splice sites, promoter) at >1000× depth | Limited to 3–4 known hotspots; may miss novel variants |
| Method | Next‑Generation Sequencing (NGS) + ACMG 2026 variant interpretation & in silico predictors | Sanger sequencing with manual analysis |
| Turnaround Time | 3–4 weeks (expedited reporting available) | 5–8 weeks |
Physician Insight & Safety Protocol
“As a diabetologist who has guided hundreds of families through the MODY journey, I want you to know that a genetic finding is not a verdict but a roadmap. A positive NKX2‑2 result must always be interpreted alongside your clinical picture and family tree – it often means you can switch from insulin to pills, but never without your endocrinologist’s supervision.” – Dr. PRABHAKAR REDDY, Specialist Diabetologist (DHA: 61713011)
⚠ Medication Warning: Do not discontinue, adjust, or change any prescribed diabetes medication based solely on this test result. Always consult your treating physician.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients who received allogeneic bone marrow / stem cell transplant within the last 6 months (risk of donor‑DNA contamination).
- Exclusion: Individuals unable to provide informed consent or, for minors, without legal guardian authorisation as per UAE CDS Law 2026.
- ER Red Flag: This is an elective, non‑urgent test. Seek immediate emergency care if you experience severe hyperglycaemia (blood glucose > 300 mg/dL), ketotic breath, vomiting, or altered consciousness.
UAE Regulatory Compliance
✓ Genetic testing conducted under Federal Decree‑Law No. 41 of 2024 (Art. 87) – strict informed consent and result confidentiality.
✓ Minors’ testing adheres to CDS Law 2026 requiring guardian consent and mandatory genetic counselling.
✓ All patient data processed per UAE PDPL – end‑to‑end encryption, sovereign data storage.
✓ Facility licensed by DHA #9834453 and ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Patient FAQ & Clinical Guidance
1. What is NKX2‑2 MODY genetic testing and who should consider it?
In brief: NKX2‑2 NGS sequencing detects inherited mutations in the NKX2‑2 gene that cause a monogenic form of diabetes often misdiagnosed as Type 1 or Type 2, enabling precise treatment modification.
يقوم تحليل التسلسل الجيني لجين NKX2‑2 بالكشف عن الطفرات الموروثة المسببة لمرض السكري الشبابي الناضج الذي يُشخَّص خطأً على أنه نمط أول أو ثاني، مما يسمح بتعديل العلاج بشكل دقيق.
2. How accurate is this NGS test compared to conventional genetic testing?
In brief: Our NGS panel delivers 99.9% analytical sensitivity and specificity by sequencing the entire NKX2‑2 coding region at high depth, reducing false negatives seen in targeted hotspot panels.
يقدم اختبارنا دقة تحليلية تصل إلى 99.9% بفضل تقنية التسلسل الكامل للجين بعمق عالي، مما يقلل من النتائج السلبية الكاذبة التي تحدث في فحوصات النقاط الساخنة المحدودة.
3. How should I prepare for the and when will I get my results?
In brief: No fasting or medication changes are required; a single blood draw or buccal swab collected by our DHA‑licensed phlebotomist yields results in just 3–4 weeks.
لا حاجة للصيام أو تغيير الأدوية؛ يكفي سحب عينة دم واحدة أو مسحة فموية يقوم بها أخصائي معتمد من هيئة الصحة بدبي، وستحصل على النتيجة خلال 3–4 أسابيع فقط.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians